Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades7
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Faron Pharmaceuticals Information
Share Price Information for Faron Pharmaceuticals (FARN)
Share Price is delayed by 15 minutes
Get Live Data
46.00
0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread:
2.00 (4.444%)
Market Cap:
£91.78m
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals News
26 Aug 2021
TRADING UPDATES: Glenveagh, IOG swing to profit; Faron loss widens
TRADING UPDATES: Glenveagh, IOG swing to profit; Faron loss widens
25 Aug 2021
Faron doses first patient in Covid-19 treatment trial
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Wednesday that the first patient has been dosed in the...
25 Aug 2021
IN BRIEF: Faron Pharmaceuticals begins study of new Covid treatment
IN BRIEF: Faron Pharmaceuticals begins study of new Covid treatment
19 Aug 2021
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
14 Jun 2021
Faron Pharmaceuticals granted US patent for cancer immunotherapy drug
Faron Pharmaceuticals granted US patent for cancer immunotherapy drug
3 Jun 2021
BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall
BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall
3 Jun 2021
New research supports mode of action in Faron's 'MATINS' study
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced the publication of research supporting the immunotherapeut...
17 May 2021
TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch
TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch
Follow the stocks
